ANDA 89395, held by Hikma. Vinblastine Sulfate.
As of Nov 16, 2026, ANDA 89395 (Vinblastine Sulfate), held by Hikma, was first approved by FDA on Apr 9, 1987, with 9 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 9, 1987 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Vinblastine Sulfate10MG/VIAL ยท injectable;injection | Vinblastine Sulfate | Rx |
| Aug 22, 2002 | Supplement 9Labeling | Approved | None posted |
| Dec 21, 2000 | Supplement 8Manufacturing | Approved | None posted |
| Sep 5, 1997 | Supplement 7Labeling | Approved | None posted |
| Feb 25, 1994 | Supplement 6Manufacturing | Approved | None posted |
| Apr 30, 1993 | Supplement 5Labeling | Approved | None posted |
| Apr 2, 1993 | Supplement 4Labeling | Approved | None posted |
| Apr 24, 1989 | Supplement 3Labeling | Approved | None posted |
| Apr 13, 1988 | Supplement 2Manufacturing | Approved | None posted |
| Apr 13, 1988 | Supplement 1Manufacturing | Approved | None posted |
| Apr 9, 1987 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters